About this Journal Submit a Manuscript Table of Contents
Obstetrics and Gynecology International
Volume 2012 (2012), Article ID 953937, 11 pages
http://dx.doi.org/10.1155/2012/953937
Review Article

Cancer, Fertility Preservation, and Future Pregnancy: A Comprehensive Review

1Department of Obstetrics and Gynecology, Carolinas Medical Center, P.O. Box 32861, Charlotte, NC 28232, USA
2Blumenthal Cancer Center, Carolinas Medical Center, 1025 Morehead Medical Drive, Charlotte, NC 28204, USA

Received 13 September 2011; Accepted 5 December 2011

Academic Editor: Einat Shalom-Paz

Copyright © 2012 Michelle L. Matthews et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. Cancer Facts and Figures, American Cancer Society, Atlanta, Ga, USA, 2011.
  2. A. Jemal, T. Murray, E. Ward et al., “Cancer statistics, 2005,” CA: Cancer Journal for Clinicians, vol. 55, no. 1, pp. 10–30, 2005. View at Scopus
  3. J. Carter, D. S. Chi, C. L. Brown et al., “Cancer-related infertility in survivorship,” International Journal of Gynecological Cancer, vol. 20, no. 1, pp. 2–8, 2010. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  4. A. H. Partridge, S. Gelber, J. Peppercorn et al., “Web-based survey of fertility issues in young women with breast cancer,” Journal of Clinical Oncology, vol. 22, no. 20, pp. 4174–4183, 2004. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  5. J. Carter, L. Raviv, L. Applegarth et al., “A cross-sectional study of the psychosexual impact of cancer-related infertility in women: third-party reproductive assistance,” Journal of Cancer Survivorship, vol. 4, no. 3, pp. 236–246, 2010. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  6. S. J. Lee, L. R. Schover, A. H. Partridge et al., “American Society of Clinical Oncology recommendations on fertility preservation in cancer patients,” Journal of Clinical Oncology, vol. 24, no. 18, pp. 2917–2931, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  7. G. P. Quinn, S. T. Vadaparampil, J. H. Lee et al., “Physician referral for fertility preservation in oncology patients: a national study of practice behaviors,” Journal of Clinical Oncology, vol. 27, no. 35, pp. 5952–5957, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  8. E. J. Forman, C. K. Anders, and M. A. Behera, “A nationwide survey of oncologists regarding treatment-related infertility and fertility preservation in female cancer patients,” Fertility and Sterility, vol. 94, no. 5, pp. 1652–1656, 2010. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  9. S. Lee, E. Heytens, F. Moy, S. Ozkavukcu, and K. Oktay, “Determinants of access to fertility preservation in women with breast cancer,” Fertility and Sterility, vol. 95, no. 6, pp. 1931–1936, 2011. View at Publisher · View at Google Scholar · View at PubMed
  10. M. R. Viera, S. Liu, A. Idriss, and P. Stratton, “Conveying future fertility risk to patients participating in clinical trials using total body irradiation or cytotoxic agents,” Fertility and Sterility, vol. 92, supplement 3, p. S184, 2009.
  11. M. Bianchi, “Cytotoxic insult to germinal tissue—part 2: the ovary,” in Cytotoxic Insult to Tissue: Effects on Cell Lineages, C. S. Potten and J. H. Hendry, Eds., pp. 309–328, Churchill- Livingstone, Edinburgh, UK, 1983.
  12. W. H. B. Wallace, A. B. Thomson, and T. W. Kelsey, “The radiosensitivity of the human oocyte,” Human Reproduction, vol. 18, no. 1, pp. 117–121, 2003. View at Publisher · View at Google Scholar · View at Scopus
  13. H. O. Critchley and W. H. Wallace, “Impact of cancer treatment on uterine function,” Journal of the National Cancer Institute Monographs, no. 34, pp. 64–68, 2005. View at Scopus
  14. H. O.D. Critchley, C. H. Buckley, and D. C. Anderson, “Experience with a ‘physiological’ steroid replacement regimen for the establishment of a receptive endometrium in women with premature ovarian failure,” British Journal of Obstetrics and Gynaecology, vol. 97, no. 9, pp. 804–810, 1990.
  15. E. D. Larsen, K. Schmiegelow, C. Rechnitzer, et al., “Radiotherapy at a young age reduced uterine volume of childhood cancer survivors,” Acta Obstetricia et Gynecologica Scandinavica, vol. 83, pp. 96–102, 2004.
  16. T. Ajala, J. Rafi, P. Larsen-Disney, and R. Howell, “Fertility preservation for cancer patents: a review,” Obstetrics and Gynecology International, vol. 2010, Article ID 160386, 9 pages, 2010.
  17. R. T. Scott, M. S. Opsahl, M. R. Leonardi, G. S. Neall, E. H. Illions, and D. Navot, “Life table analysis of pregnancy rates in a general infertility population relative to ovarian reserve and patient age,” Human Reproduction, vol. 10, no. 7, pp. 1706–1710, 1995. View at Scopus
  18. I. A. J. Van Rooij, F. J. M. Broekmans, G. J. Scheffer et al., “Serum antimüllerian hormone levels best reflect the reproductive decline with age in normal women with proven fertility: a longitudinal study,” Fertility and Sterility, vol. 83, no. 4, pp. 979–987, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  19. D. J. Hendriks, B. W. J. Mol, L. F. Bancsi, E. R. Te Velde, and F. J. M. Broekmans, “Antral follicle count in the prediction of poor ovarian response and pregnancy after in vitro fertilization: a meta-analysis and comparison with basal follicle-stimulating hormone level,” Fertility and Sterility, vol. 83, no. 2, pp. 291–301, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  20. H. I. Su, “Measuring ovarian function in young cancer survivors,” Minerva Endocrinologica, vol. 35, no. 4, pp. 259–270, 2010.
  21. R. A. Anderson and D. A. Cameron, “Pretreatment serum anti-müllerian hormone predicts long-term ovarian function and bone mass after chemotherapy for early breast cancer,” Journal of Clinical Endocrinology and Metabolism, vol. 96, no. 5, pp. 1336–1343, 2011. View at Publisher · View at Google Scholar · View at PubMed
  22. R. A. Anderson and W. H. B. Wallace, “Fertility preservation in girls and young women,” Clinical Endocrinology, vol. 75, no. 4, pp. 409–419, 2011. View at Publisher · View at Google Scholar · View at PubMed
  23. M. R. S. Cruz, J. C. Prestes, D. L. Gimenes, and M. F. Fanelli, “Fertility preservation in women with breast cancer undergoing adjuvant chemotherapy: a systematic review,” Fertility and Sterility, vol. 94, no. 1, pp. 138–143, 2010. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  24. F. Recchia, G. Saggio, G. Amiconi et al., “Gonadotropin-releasing hormone analogues added to adjuvant chemotherapy protect ovarian function and improve clinical outcomes in young women with early breast carcinoma,” Cancer, vol. 106, no. 3, pp. 514–523, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  25. M. C. Hulvat and J. S. Jeruss, “Maintaining fertility in young women with breast cancer,” Current Treatment Options in Oncology, vol. 10, no. 5-6, pp. 308–317, 2009. View at Publisher · View at Google Scholar · View at PubMed
  26. R. Riggs, J. Mayer, D. Dowling-Lacey, T. F. Chi, E. Jones, and S. Oehninger, “Does storage time influence postthaw survival and pregnancy outcome? An analysis of 11,768 cryopreserved human embryos,” Fertility and Sterility, vol. 93, no. 1, pp. 109–115, 2010. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  27. Ethics Committee of the American Society for Reproductive Medicine, “Fertility preservation and reproduction in cancer patients,” Fertility and Sterility, vol. 83, no. 6, pp. 1622–1628, 2005.
  28. C. Chen, “Pregnancy after human oocyte cryopreservation,” Lancet, vol. 1, no. 8486, pp. 884–886, 1986. View at Scopus
  29. J. Saragusty and A. Arav, “Current progress in oocyte and embryo cryopreservation by slow freezing and vitrification,” Reproduction, vol. 141, no. 1, pp. 1–19, 2011. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  30. E. Porcu, A. Bazzocchi, L. Notarangelo, R. Paradisi, C. Landolfo, and S. Venturoli, “Human oocyte cryopreservation in infertility and oncology,” Current Opinion in Endocrinology, Diabetes and Obesity, vol. 15, no. 6, pp. 529–535, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  31. A. Cobo and C. Diaz, “Clinical application of oocyte vitrification: a systematic review and meta-analysis of randomized controlled trials,” Fertility and Sterility, vol. 96, no. 2, pp. 277–285, 2011. View at Publisher · View at Google Scholar · View at PubMed
  32. K. Oktay, E. Buyuk, L. Veeck et al., “Embryo development after heterotopic transplantation of cryopreserved ovarian tissue,” Lancet, vol. 363, no. 9412, pp. 837–840, 2004. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  33. M. Rosendahl, A. Loft, A. G. Byskov et al., “Biochemical pregnancy after fertilization of an oocyte aspirated from a heterotopic autotransplant of cryopreserved ovarian tissue: case Report,” Human Reproduction, vol. 21, no. 8, pp. 2006–2009, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  34. K. Oktay and G. Karlikaya, “Ovarian function after transplantation of frozen, banked autologous ovarian tissue,” The New England Journal of Medicine, vol. 342, no. 25, p. 1919, 2000. View at Publisher · View at Google Scholar · View at Scopus
  35. J. Donnez, M. M. Dolmans, D. Demylle, et al., “Live birth after orthotopic transplantation of cryopreserved ovarian tissue,” Lancet, vol. 364, pp. 1405–1410, 2004.
  36. E. Ernst, S. Bergholdt, J. S. Jørgensen, and C. Y. Andersen, “The first woman to give birth to two children following transplantation of frozen/thawed ovarian tissue,” Human Reproduction, vol. 25, no. 5, pp. 1280–1281, 2010. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  37. R. C. Chian, J. Y. J. Huang, L. Gilbert et al., “Obstetric outcomes following vitrification of in vitro and in vivo matured oocytes,” Fertility and Sterility, vol. 91, no. 6, pp. 2391–2398, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  38. M. Sönmezer, I. Türküolu, U. Cokun, and K. Oktay, “Random-start controlled ovarian hyperstimulation for emergency fertility preservation in letrozole cycles,” Fertility and Sterility, vol. 95, no. 6, pp. 2125.e9–225.e11, 2011. View at Publisher · View at Google Scholar · View at PubMed
  39. K. Oktay, E. Buyuk, O. Davis, I. Yermakova, L. Veeck, and Z. Rosenwaks, “Fertility preservation in breast cancer patients: IVF and embryo cryopreservation after ovarian stimulation with tamoxifen,” Human Reproduction, vol. 18, no. 1, pp. 90–95, 2003. View at Publisher · View at Google Scholar · View at Scopus
  40. K. Oktay, “Further evidence on the safety and success of ovarian stimulation with letrozole and tamoxifen in breast cancer patients undergoing in vitro fertilization to cryopreserve their embryos for fertility preservation,” Journal of Clinical Oncology, vol. 23, no. 16, pp. 3858–3860, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  41. Z. P. Nagy, C. C. Chang, H. I. Kort, A. A. Toledo, S. M. Slayden, and D. B. Shapiro, “Comparison of vitrified/warmed donated oocyte treatment outcomes in GnRH-antagonist cycles where hCG or Lupron was used to trigger ovulation,” Fertility and Sterility, vol. 94, no. 4, pp. s160–s161, 2010.
  42. A. Rosen, “Third-party reproduction and adoption in cancer patients,” Journal of the National Cancer Institute, no. 34, pp. 91–93, 2005.
  43. L. Campo-Engelstein, “Consistency in insurance coverage for iatrogenic conditions resulting from cancer treatment including fertility preservation,” Journal of Clinical Oncology, vol. 28, no. 8, pp. 1284–1286, 2010. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  44. L. N. Beck, M. Sileo, and A. B. Copperman, “The average cost of fertility preservation for female cancer patients,” Fertility and Sterility, vol. 94, no. 4, p. s105, 2010.
  45. B. E. Friedman, K. O’Leary, and L. M. Westphal, “Follow-up survey of cancer survivors who underwent ovarian stimulation for fertility preservation,” Fertility and Sterility, vol. 95, no. 4, supplement, pp. S12–S13, 2011.
  46. S. D. Fosså, H. Magelssen, K. Melve, A. B. Jacobsen, F. Langmark, and R. Skjaerven, “Parenthood in survivors after adulthood cancer and perinatal health in their offspring: a preliminary report,” Journal of the National Cancer Institute. Monographs, no. 34, pp. 77–82, 2005.
  47. E. De Bree, A. Makrigiannakis, J. Askoxylakis, J. Melissas, and D. D. Tsiftsis, “Pregnancy after breast cancer. A comprehensive review,” Journal of Surgical Oncology, vol. 101, no. 6, pp. 534–542, 2010. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  48. E. Fenig, M. Mishaeli, Y. Kalish, and M. Lishner, “Pregnancy and radiation,” Cancer Treatment Reviews, vol. 27, no. 1, pp. 1–7, 2001. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  49. B. A. Mueller, E. J. Chow, A. Kamineni et al., “Pregnancy outcomes in female childhood and adolescent cancer survivors: a linked cancer-birth registry analysis,” Archives of Pediatrics and Adolescent Medicine, vol. 163, no. 10, pp. 879–886, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  50. P. Harper, Practical Genetic Counseling, Hodder Arnold, London, UK, 6th edition, 2004.
  51. N. Rahner and V. Steinke, “Hereditary cancer syndromes,” Deutsches Arzteblatt, vol. 105, no. 41, pp. 706–714, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  52. K. Offit, K. Kohut, B. Clagett et al., “Cancer genetic testing and assisted reproduction,” Journal of Clinical Oncology, vol. 24, no. 29, pp. 4775–4782, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  53. K. Hudson, S. Baruch, and G. Javitt, “Genetic testing of human embryos: ethical challenges and policy choices,” in Expanding Horizons in Bioethics, A. Galson and C. Peppard, Eds., pp. 103–122, Springer, Dordrecht, The Netherlands, 2005.
  54. G. Quinn, S. Vadaparampil, C. Wilson et al., “Attitudes of high-risk women toward preimplantation genetic diagnosis,” Fertility and Sterility, vol. 91, no. 6, pp. 2361–2368, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  55. R. Sankila, S. Heinavaara, and T. Hakulinen, “Survival of breast cancer patients after subsequent term pregnancy: “Healthy mother effect”,” American Journal of Obstetrics and Gynecology, vol. 170, no. 3, pp. 818–823, 1994. View at Scopus
  56. J. C. Harvey, P. P. Rosen, R. Ashikari, et al., “The effect of pregnancy on the prognosis of carcinoma of the breast following radical mastectomy,” Surgery Gynecology and Obstetrics, vol. 153, no. 5, pp. 723–725, 1981. View at Scopus
  57. L. Mignot, F. Morvan, J. Berdah, et al., “Pregnancy after breast-cancer. Results of a case-control study,” Presse Medicale, vol. 15, no. 39, pp. 1961–1964, 1986. View at Scopus
  58. B. A. Mueller, M. S. Simon, D. Deapen, A. Kamineni, K. E. Malone, and J. R. Daling, “Childbearing and survival after breast carcinoma in young women,” Cancer, vol. 98, no. 6, pp. 1131–1140, 2003. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  59. R. M. Clark and T. Chua, “Breast cancer and pregnancy: the ultimate challenge,” Clinical Oncology, vol. 1, no. 1, pp. 11–18, 1989. View at Scopus
  60. A. Ives, C. Saunders, M. Bulsara, and J. Semmens, “Pregnancy after breast cancer: population based study,” British Medical Journal, vol. 334, no. 7586, pp. 194–196, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  61. H. A. Azim, L. Santoro, N. Pavlidis et al., “Safety of pregnancy following breast cancer diagnosis: a meta-analysis of 14 studies,” European Journal of Cancer, vol. 47, no. 1, pp. 74–83, 2011. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  62. A. Valachis, L. Tsali, L. L. Pesce et al., “Safety of pregnancy after primary breast carcinoma in young women: a meta-analysis to overcome bias of healthy mother effect studies,” Obstetrical and Gynecological Survey, vol. 65, no. 12, pp. 786–793, 2010. View at Publisher · View at Google Scholar · View at PubMed
  63. S. Asztalos, P. H. Gann, M. K. Hayes et al., “Gene expression patterns in the human breast after pregnancy,” Cancer Prevention Research, vol. 3, no. 3, pp. 301–311, 2010. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  64. O. Pagani, K. N. Price, R. D. Gelber et al., “Patterns of recurrence of early breast cancer according to estrogen receptor status: a therapeutic target for a quarter of a century,” Breast Cancer Research and Treatment, vol. 117, no. 2, pp. 319–324, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  65. M. H. Shiu, D. Schottenfeld, B. Maclean, and J. G. Fortner, “Adverse effect of pregnancy on melanoma: a reappraisal,” Cancer, vol. 37, no. 1, pp. 181–187, 1976. View at Scopus
  66. C. Riberti, G. Mrola, and A. Vertani, “Malignant melanoma: the adverse effect of pregnancy,” British Journal of Plastic Surgery, vol. 34, pp. 338–339, 1981.
  67. A.-S. Chao, A. Chao, C.-J. Wang, C.-H. Lai, and H.-S. Wang, “Obstetric outcomes of pregnancy after conservative treatment of endometrial cancer: case series and literature review,” Taiwanese Journal of Obstetrics and Gynecology, vol. 50, no. 1, pp. 62–66, 2011. View at Publisher · View at Google Scholar · View at PubMed
  68. I. Kalogiannidis and T. Agorastos, “Conservative management of young patients with endometrial highly-differentiated adenocarcinoma,” Journal of Obstetrics and Gynaecology, vol. 31, no. 1, pp. 13–17, 2011. View at Publisher · View at Google Scholar · View at PubMed